HIGHLIGHTS
- who: A.A. Toorop from the Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Neurology Outpatient Clinic, De Boelelaan, HV, Amsterdam, the Netherlands have published the research: The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis, in the Journal: (JOURNAL)
- what: The aims of this study were to investigate the prevalence of the wearing-off phenomenon in patients with MS using ocrelizumab, to detect possible risk factors and to evaluate if the wearing-off phenom enon is also reflected in physical or psychological changes after ocreli . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.